{"count": 6, "results": [{"_id": "35720480", "pmid": 35720480, "pmcid": "PMC9178677", "title": "Metformin: A promising drug for human cancers", "journal": "Oncol Lett", "authors": ["Wu H", "Huang D", "Zhou H", "Sima X", "Wu Z", "Sun Y", "Wang L", "Ruan Y", "Wu Q", "Wu F", "She T", "Chu Y", "Huang Q", "Ning Z", "Zhang H"], "date": "2022-05-12T00:00:00Z", "doi": "10.3892/ol.2022.13325", "meta_date_publication": "2022 Jul", "meta_volume": "24", "meta_issue": "1", "meta_pages": "204", "score": 50263.652, "text_hl": "Epidemiological data and in vivo, and in vitro experiments have shown that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can reduce the incidence of @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and has a strong antagonistic effect on @<m>DISEASE_Cancer_Pain</m> @DISEASE_MESH:D000072716 @@@metabolism-related tumors@@@. ", "citations": {"NLM": "Wu H, Huang D, Zhou H, Sima X, Wu Z, Sun Y, Wang L, Ruan Y, Wu Q, Wu F, She T, Chu Y, Huang Q, Ning Z, Zhang H. Metformin: A promising drug for human cancers Oncol Lett. 2022 Jul;24(1):204. PMID: 35720480", "BibTeX": "@article{35720480, title={Metformin: A promising drug for human cancers}, author={Wu H and Huang D and Zhou H and Sima X and Wu Z and Sun Y and Wang L and Ruan Y and Wu Q and Wu F and She T and Chu Y and Huang Q and Ning Z and Zhang H}, journal={Oncol Lett}, volume={24}, number={1}, pages={204}}"}}, {"_id": "36823364", "pmid": 36823364, "pmcid": "PMC10006178", "title": "Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?", "journal": "Br J Cancer", "authors": ["Lord SR", "Harris AL"], "date": "2023-04-01T00:00:00Z", "doi": "10.1038/s41416-023-02204-2", "meta_date_publication": "2023 Apr", "meta_volume": "128", "meta_issue": "6", "meta_pages": "958-966", "score": 50262.98, "text_hl": "This perspective article summarises how interest initially developed in the @<m>DISEASE_Cancer_Pain</m> @DISEASE_MESH:D000072716 @@@oncological@@@ potential of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and the diverse clinical programme of work to date including our contribution to establishing the intra-tumoral pharmacodynamic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in the clinic. ", "citations": {"NLM": "Lord SR, Harris AL. Is it still worth pursuing the repurposing of metformin as a cancer therapeutic? Br J Cancer. 2023 Apr;128(6):958-966. PMID: 36823364", "BibTeX": "@article{36823364, title={Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?}, author={Lord SR and Harris AL}, journal={Br J Cancer}, volume={128}, number={6}, pages={958-966}}"}}, {"_id": "37815561", "pmid": 37815561, "pmcid": "PMC10796410", "title": "Bidirectional pharmacokinetic drug interactions between olaparib and metformin", "journal": "Cancer Chemother Pharmacol", "authors": ["Stanisławiak-Rudowicz J", "Karbownik A", "Szkutnik-Fiedler D", "Otto F", "Grabowski T", "Wolc A", "Grześkowiak E", "Szałek E"], "date": "2023-10-10T00:00:00Z", "doi": "10.1007/s00280-023-04591-y", "meta_date_publication": "2023 Oct 10", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50252.355, "text_hl": "...HPLC-UV assay of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@", "citations": {"NLM": "Stanisławiak-Rudowicz J, Karbownik A, Szkutnik-Fiedler D, Otto F, Grabowski T, Wolc A, Grześkowiak E, Szałek E. Bidirectional pharmacokinetic drug interactions between olaparib and metformin Cancer Chemother Pharmacol. 2023 Oct 10;():. PMID: 37815561", "BibTeX": "@article{37815561, title={Bidirectional pharmacokinetic drug interactions between olaparib and metformin}, author={Stanisławiak-Rudowicz J and Karbownik A and Szkutnik-Fiedler D and Otto F and Grabowski T and Wolc A and Grześkowiak E and Szałek E}, journal={Cancer Chemother Pharmacol}}"}}, {"_id": "22465829", "pmid": 22465829, "title": "Metformin and pancreatic cancer: a clue requiring investigation.", "journal": "Clin Cancer Res", "authors": ["Pollak M"], "date": "2012-05-15T00:00:00Z", "doi": "10.1158/1078-0432.CCR-12-0694", "meta_date_publication": "2012 May 15", "meta_volume": "18", "meta_issue": "10", "meta_pages": "2723-5", "score": 50060.418, "text_hl": "However, gaps in knowledge must be addressed before @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can be \"repurposed\" for @<m>DISEASE_Cancer_Pain</m> @DISEASE_MESH:D000072716 @@@oncologic@@@ indications.", "citations": {"NLM": "Pollak M. Metformin and pancreatic cancer: a clue requiring investigation. Clin Cancer Res. 2012 May 15;18(10):2723-5. PMID: 22465829", "BibTeX": "@article{22465829, title={Metformin and pancreatic cancer: a clue requiring investigation.}, author={Pollak M}, journal={Clin Cancer Res}, volume={18}, number={10}, pages={2723-5}}"}}, {"_id": "24113620", "pmid": 24113620, "title": "Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.", "journal": "Eur J Surg Oncol", "authors": ["Rieken M", "Xylinas E", "Kluth L", "Trinh QD", "Lee RK", "Fajkovic H", "Novara G", "Margulis V", "Lotan Y", "Martinez-Salamanca JI", "Matsumoto K", "Seitz C", "Remzi M", "Karakiewicz PI", "Scherr DS", "Briganti A", "Kautzky-Willer A", "Bachmann A", "Shariat SF", "UTUC Collaboration"], "date": "2014-01-01T00:00:00Z", "doi": "10.1016/j.ejso.2013.09.016", "meta_date_publication": "2014 Jan", "meta_volume": "40", "meta_issue": "1", "meta_pages": "113-20", "score": 50056.418, "text_hl": "@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes mellitus@@@ without @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ intake is associated with worse @<m>DISEASE_Cancer_Pain</m> @DISEASE_MESH:D000072716 @@@oncologic@@@ outcomes after radical nephroureterectomy for @DISEASE_Respiratory_Tract_Infections @DISEASE_MESH:D012141 @@@upper tract urothelial carcinoma@@@.", "citations": {"NLM": "Rieken M, Xylinas E, Kluth L, Trinh QD, Lee RK, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Kautzky-Willer A, Bachmann A, Shariat SF, UTUC Collaboration. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur J Surg Oncol. 2014 Jan;40(1):113-20. PMID: 24113620", "BibTeX": "@article{24113620, title={Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.}, author={Rieken M and Xylinas E and Kluth L and Trinh QD and Lee RK and Fajkovic H and Novara G and Margulis V and Lotan Y and Martinez-Salamanca JI and Matsumoto K and Seitz C and Remzi M and Karakiewicz PI and Scherr DS and Briganti A and Kautzky-Willer A and Bachmann A and Shariat SF and UTUC Collaboration}, journal={Eur J Surg Oncol}, volume={40}, number={1}, pages={113-20}}"}}, {"_id": "26097049", "pmid": 26097049, "title": "The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.", "journal": "Urol Oncol", "authors": ["Nayan M", "Bhindi B", "Yu JL", "Hermanns T", "Mohammed A", "Hamilton RJ", "Finelli A", "Jewett MA", "Zlotta AR", "Fleshner NE", "Kulkarni GS"], "date": "2015-09-01T00:00:00Z", "doi": "10.1016/j.urolonc.2015.05.024", "meta_date_publication": "2015 Sep", "meta_volume": "33", "meta_issue": "9", "meta_pages": "386.e7-13", "score": 50046.53, "text_hl": "Our objective was to evaluate the association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and @<m>DISEASE_Cancer_Pain</m> @DISEASE_MESH:D000072716 @@@oncologic@@@ outcomes in @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ undergoing radical cystectomy (RC) for @DISEASE_Urinary_Bladder_Neoplasms @DISEASE_MESH:D001749 @@@bladder cancer@@@ (@DISEASE_Urinary_Bladder_Neoplasms @DISEASE_MESH:D001749 @@@BC@@@). ", "citations": {"NLM": "Nayan M, Bhindi B, Yu JL, Hermanns T, Mohammed A, Hamilton RJ, Finelli A, Jewett MA, Zlotta AR, Fleshner NE, Kulkarni GS. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Urol Oncol. 2015 Sep;33(9):386.e7-13. PMID: 26097049", "BibTeX": "@article{26097049, title={The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.}, author={Nayan M and Bhindi B and Yu JL and Hermanns T and Mohammed A and Hamilton RJ and Finelli A and Jewett MA and Zlotta AR and Fleshner NE and Kulkarni GS}, journal={Urol Oncol}, volume={33}, number={9}, pages={386.e7-13}}"}}]}